Breztri Aerosphere Now Available in the US for Asthma
AstraZeneca's triple-combination asthma therapy Breztri Aerosphere was approved in April 2026 for adults and pediatric patients age 12 and older.
AstraZeneca's triple-combination asthma therapy Breztri Aerosphere was approved in April 2026 for adults and pediatric patients age 12 and older.
A fatty acid in breast milk programs immune cells to fight infections and may reduce the risk of chronic lung disease in premature infants.
ICU mortality rates during the pandemic were significantly lower in ICUs that exhibited high efficiency, pre-COVID-19.
Women's attitudes and beliefs regarding sleep during pregnancy are significant predictors of sleep disruption after delivery.
Researchers at UC San Diego developed a new scale to measure how social norms around cigarette...
The BreatheLink platform allows patients to transmit overnight oximetry data from their own smartphones, reducing the time required to set up home oxygen therapy.